Prophylactic indomethacin worsens short-term respiratory outcomes in extremely low-birth-weight infants

American Journal of Perinatology

Volumn 31, Issue 1, 2014, Pages 61-68

  Mondal, Tapas ^a   Chaudhuri, Dipayan ^a   Li, Brian ^a   Shivananda, Sandesh ^a   Dutta, Sourabh ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

indomethacin prophylaxis; patent ductus arteriosus

Indexed keywords

INDOMETACIN;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONTROLLED STUDY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; POSITIVE END EXPIRATORY PRESSURE; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; SHORT TERM RESPIRATORY OUTCOME; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; CEREBRAL HEMORRHAGE; CONTINUOUS POSITIVE AIRWAY PRESSURE; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; LENGTH OF STAY; MALE; OXYGEN INHALATION THERAPY; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TIME FACTORS; WATCHFUL WAITING;

EID: 84891825644     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1334449     Document Type: Article

References (25)

1. Madan J. C., Kendrick D., Hagadorn J. I., Frantz I. D. III. National Institute of Child Health and Human Development Neonatal Research Network Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics: 2009; 123 674 681
2. Fowlie P. W., Davis P. G. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed: 2003; 88 F464 F466
3. Hermes-DeSantis E. R., Clyman R. I. Patent ductus arteriosus: pathophysiology and management. J Perinatol: 2006; 26 01 S14 S18, discussion S22-S23
4. Ment L. R., Oh W., Ehrenkranz R. A., et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics: 1994; 93 543 550
5. Schmidt B., Roberts R. S., Fanaroff A., et al. TIPP Investigators. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr: 2006; 148 730 734
6. Schmidt B., Davis P., Moddemann D., et al. Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med: 2001; 344 1966 1972
7. Ment L. R., Vohr B., Allan W., et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics: 2000; 105 3 Pt 1 485 491
8. Amin S. B., Handley C., Carter-Pokras O. Indomethacin use for the management of patent ductus arteriosus in preterms: a web-based survey of practice attitudes among neonatal fellowship program directors in the United States. Pediatr Cardiol: 2007; 28 193 200
9. Hoellering A. B., Cooke L. The management of patent ductus arteriosus in Australia and New Zealand. J Paediatr Child Health: 2009; 45 204 209
10. Cordero L., Nankervis C. A., Delooze D., Giannone P. J. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants? J Perinatol: 2007; 27 158 163
11. Fan J. L., Burgess K. R., Thomas K. N., et al. Influence of indomethacin on ventilatory and cerebrovascular responsiveness to CO2 and breathing stability: the influence of PCO2 gradients. Am J Physiol Regul Integr Comp Physiol: 2010; 298 R1648 R1658
12. Vincer M., Allen A., Evans J., et al. Early intravenous indomethacin prolongs respiratory support in very low birth weight infants. Acta Paediatr Scand: 1987; 76 894 897
13. Clyman R. I., Chorne N. Patent ductus arteriosus: evidence for and against treatment. J Pediatr: 2007; 150 216 219
14. Fanasoff A. A., Stoll B. J., Wright L. L., et al. Trends in Neonatal mortality and morbidity for very low birth weight infants. Am J Obstet Gynecol: 2007; e1 147
15. Van O. B., Van de Broek H., Van L. P., et al. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr: 2001; 138 205 211
16. Cifuentes R. F., Olley P. M., Balfe J. W., Radde I. C., Soldin S. J. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr: 1979; 95 583 587
17. Lago P., Bettiol T., Salvadori S., et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr: 2002; 161 202 207
18. Tommiska V., Heinonen K., Ikonen S., et al. A national short-term follow-up study of extremely low birth weight infants born in Finland in 1996-1997. Pediatrics: 2001; 107 E2
19. Tommiska V., Heinonen K., Lehtonen L., et al. No improvement in outcome of nationwide extremely low birth weight infant populations between 1996-1997 and 1999-2000. Pediatrics: 2007; 119 29 36
20. Valcamonico A., Accorsi P., Sanzeni C., et al. Mid- and long-term outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors. J Matern Fetal Neonatal Med: 2007; 20 465 471
21. Crowther C. A., Haslam R. R., Hiller J. E., Doyle L. W., Robinson J. S.; Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet: 2006; 367 1913 1919
22. Hayes E. J., Paul D. A., Stahl G. E., et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet Gynecol: 2008; 111 921 926
23. Kumar Nair P. A., Pai M. G., Gazal H. A., Da Costa D. E., Al Khusaiby S. M. Indomethacin prophylaxis for intraventricular hemorrhage in very low birth weight babies. Indian Pediatr: 2004; 41 551 558
24. Hanigan W. C., Kennedy G., Roemisch F., Anderson R., Cusack T., Powers W. Administration of indomethacin for the prevention of periventricular- intraventricular hemorrhage in high-risk neonates. J Pediatr: 1988; 112 941 947
25. Fowlie P. W., Davis P. G., McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev: 2010; 7 CD000174